Shire's Suitors: Takeda, Pfizer Seen As Likely To Bid; Amgen Could Enter Fray

 
• By Joseph Haas
Risk versus value matrix with pushpins and blur effect. Concept of investment risk assessment.

More from Deals

More from Business